UCLA Integrated Substance Abuse Program Programs

ISAP Mission

The UCLA Integrated Substance Abuse Programs (ISAP), organized within the Department of Psychiatry and Biobehavioral Sciences at the David Geffen School of Medicine at UCLA, works to:
•Develop and evaluate new approaches for the treatment of substance use disorders;
•Move empirically supported treatments into mainstream application through dissemination of research findings and practice improvement efforts;
•Advance the empirical understanding of substance use disorders and support efforts to ameliorate related problems through clinical training provided to physicians, counselors, and other healthcare workers;
•Investigate the epidemiology, neurobiology, health and social consequences, treatment, and prevention of substance use disorders.

ISAP: An Overview

The UCLA Integrated Substance Abuse Programs (ISAP) conducts research, provides research training and clinical training, and arranges treatment for substance use disorders in coordination with the UCLA Department of Psychiatry and Biobehavioral Sciences and in affiliation with community-based treatment providers.  ISAP efforts range from epidemiological and policy studies to basic science and human laboratory research to clinical trials of innovative behavioral therapies and pharmacotherapies.

Contract Expires: 6/4/2019